Xultophy 100 unit-3.6MG/ML pen 3ML
Ended Awarded
- Contract number
- SPE2DB25FGTDL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,637
Award facts
- Contract value 100% obligated
- $7,636.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $7,636.97 delivery order to AmerisourceBergen Drug Corp for Xultophy 100 Unit-3.6mg/mL pens (3mL quantity) with a completion date of July 29, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Xultophy is a combination insulin therapy used in diabetes management, reflecting AmerisourceBergen's extensive portfolio of pharmaceutical products supplied to federal agencies. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, AmerisourceBergen demonstrates significant capacity to fulfill federal medical procurement requirements across multiple therapeutic domains. The parent IDC enables the company to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally.
Quick answers
Who was awarded contract SPE2DB25FGTDL?
SPE2DB25FGTDL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FGTDL worth?
The government has obligated $7,637 on SPE2DB25FGTDL.
Is contract SPE2DB25FGTDL an order under another contract?
Yes. SPE2DB25FGTDL is a delivery order under SPE2DB24D2215, an indefinite delivery contract.
Was contract SPE2DB25FGTDL competed?
The extent of competition for SPE2DB25FGTDL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award